About TCB
advisory board
News & Insights
activated concepts
project felizia
contact us
TCB CAPITAL advisors

Episode 102: Building Patient-Centered Biotech Deals for a Stronger Future in Healthcare -- BIO from the BAYOU

Back to all articles
September 3, 2025

How can healthcare investment banking put patients—not just profits—at the center of biotech deals?In this episode, host James Zanewicz, JD, LLM, RTTP, speaks with Sam Libby, President and Managing Director of TCB Capital Advisors. Drawing from more than $20 billion in transactions across therapeutics, diagnostics, and digital health, Sam explains how TCB’s unique advisory model partners with companies before and after deals close. From growing up with therapist parents to founding a merchant bank, Sam shares how personal values and professional experience can come together to shape smarter strategies for healthcare innovation.In this episode, you’ll learn:

  • Why patient-centered thinking belongs at the core of investment strategy.
  • Common mistakes healthcare startups make when pitching to investors—and how to avoid them.
  • The critical role of clinical data, mission alignment, and timing in building sustainable biotech companies.

Tune in to learn how to navigate healthcare investments with purpose and ensure your biotech mission makes a lasting impact.Links:Connect with Sam Libby, and check out TCB Capital Advisors.Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine.Learn more about Clairity and Informuta.Listen to our previous episode on Drug Pricing and Accessibility.Connect with Ian McLachlan, BIO from the BAYOU producer.Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.Learn more about BIO from the BAYOU - the podcast.Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

‍

https://app.resonaterecordings.com/hosting/bio-from-the-bayou/fb1bcfe6-a724-4ba5-9344-86e6197a9f07

No items found.
About
TCB Capital advisors
TCB Capital Advisors specializes in advising on companies' buying, selling, investment, and growth strategies. TCB offers a tailored approach to each of our clients. Outside of transactions alone, work with our clients can include building a corporate development function, working with the business development team to grow revenue, or post-transaction integration and consulting services. Our ethos asserts that such services aren't isolated from transactions, but integral to supporting management towards successful expansion or exit. TCB Capital Advisors is an affiliate of Weild & Co. Securities transactions effected through Weild & Co., member FINRA/SIPC.

What’s a Rich Text element?

bullet list

  • bullet list
  1. Numebred list

numbered list

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

More Articles

see all articles

October 7, 2025

Clinical Trial Disclosure Noncompliance: What Is Its Impact on Pharma M&As?

December 16, 2025

Making Investments Into Medical Innovation With Sam Libby -- Fully Alive

© TCB Capital LLC 2024
top
All rights reserved
Houston, TX

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. TCB Capital Advisors Inc. executes all security transactions through Finalis Securities LLC and is not a registered broker-dealer, and Finalis Securities LLC and TCB Capital Advisors Inc. are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

‍Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)‍

‍TCB Capital Advisors is operated by TCB Capital Advisors Inc. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial products and is not intended as investment advice or as a confirmation of any transaction.

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.